In Brief: Medtronic Freestyle
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Freestyle: Firm introduces stentless porcine heart valve in Europe at a price of $3,800 to $4,400. The "versatile" aortic root prosthesis is treated with alpha-aminooleic acid which can help "significantly reduce the natural calcification process" and enhance the valve's durability, Medtronic says. The device's design also allows it to be "readily shaped and adapted by the surgeon for each patient." U.S. clinicals of the Freestyle are ongoing...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.